Gilead: FDA OKs Trodelvy
The FDA has approved Gilead's Trodelvy for two indications, one for monotherapy and the other for combination with pembrolizumab.
- First Indication For Monotherapy, Second For Combination With Pembrolizumab - Oks Gilead s Trodelvy For Two Indications